Alphyn Biologics announces positive results from the first cohort of a Phase IIa study in the treatment of mild to moderate atopic dermatitis

Alphyn Biologics announces positive results from the first cohort of a Phase IIa study in the treatment of mild to moderate atopic dermatitis

Annapolis, Maryland (ots/PRNewswire) – The study met all primary endpoints Alphyn Biologics, a clinical trials dermatology company developing world-class multi-target therapeutics, today announced positive results from the first cohort of …

Read more

Health – Covid test when entering from China: How does Germany proceed? – Health

Health – Covid test when entering from China: How does Germany proceed?  – Health

Berlin (dpa) – The corona wave in China is not a reason for the federal government to impose new entry restrictions. The situation is being monitored very carefully, said a …

Read more

Frank Montgomery criticizes Karl Lauterbach

General practitioners, too, are hardly expecting an improvement in the supply of medicines in the near future as a result of the latest legislative plans by Federal Health Minister Karl …

Read more

DISCOVERY LIFE SCIENCES ESTABLISHES A WORLD-CLASS PROTEOMICS SERVICES DIVISION, SUPPORTED BY LEADING TECHNOLOGY PARTNERS

Huntsville, Alabama (ots/PRNewswire) – The company creates a single source for large-scale population studies, biobank characterization and multiorganic biomarker analysis to support drug and diagnostic development Discovery Life Sciences™ (Discovery) …

Read more

Cambrex invests $16.5 million in new R&D facility in Minneapolis, Minnesota and expansion in Charles City, Iowa

Cambrex invests $16.5 million in new R&D facility in Minneapolis, Minnesota and expansion in Charles City, Iowa

East Rutherford, New Jersey (ots/PRNewswire) – Cambrex announced today that it is investing in a new 21,000 square foot research and development facility in Minneapolis, Minnesota, expanding its small molecule …

Read more